Monoclonal And Polyclonal Antibodies Research

37 researchers across 5 institutions

37 Researchers
5 Institutions
3 Grant PIs
10 High Impact

Researchers investigate the development, characterization, and application of monoclonal and polyclonal antibodies. This work addresses fundamental questions about immune system function and explores practical uses in diagnostics and therapeutics. Studies involve antibody production using various cell culture techniques, purification methods, and rigorous validation processes. Specific areas of focus include designing antibodies for targeted drug delivery, developing diagnostic assays for disease detection, and understanding antibody-mediated immune responses in health and disease. Research also examines the mechanisms by which antibodies interact with specific antigens, including those found on pathogens and cancer cells.

This research has direct relevance to Arkansas's growing bioscience sector and public health initiatives. The development of novel diagnostic tools can improve disease surveillance and early detection across the state, while antibody-based therapies hold promise for treating prevalent conditions. Understanding immune responses is crucial for addressing health challenges relevant to Arkansas's population. Furthermore, the state’s agricultural and veterinary sectors can benefit from antibody-based diagnostics and treatments for animal health.

This field draws upon expertise in molecular biology, immunology, and pharmacology. Investigations frequently intersect with studies in cancer, infectious diseases, and toxicological research. Engagement spans multiple institutions across Arkansas, fostering a collaborative environment for advancing antibody-based science and its applications.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Roland Martinꝉ UAMS 100 42,848 High Impact
Henry Ν. C. Wong UAMS 48 9,262 High Impact
Thomas Kieber‐Emmons UAMS 42 5,583
Carolina Schinke UAMS 38 5,240 High Impact
S. Michael Owens UAMS 36 3,541 High Impact
Andrew J. Pierce Ouachita Baptist University 34 7,626 High Impact
Sharmilan Thanendrarajan UAMS 32 3,699 High Impact
Dmitry A. Nedosekin UAMS 32 3,595 High Impact
W. Brooks Gentry UAMS 28 2,579 High Impact
Divaya Bhutani UAMS 25 2,670 High Impact
Behjatolah Monzavi‐Karbassi UAMS 24 1,617 Grant PI High Impact
Samer Al Hadidi UAMS 20 1,583
Ahmmed Ally University of Arkansas – Fort Smith 18 943
Jim Jin UAMS 16 797
Jessica Webber UAMS 13 707
Melinda G. Gunnell UAMS 13 541
Adam Gabriel University of Arkansas – Fort Smith 8 192
Mohammad Mamun Alam UAMS 6 102
Bhavesh Mohan Lal UAMS 5 104
Bahaa Mustafa UAMS 4 100

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
15,090 works in 2025
+2.9% CAGR 2018–2025
Leadership concentration
5.3% held by global top 5 institutions
Fragmented HHI 16
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 National Institutes of Health 5,858
  2. 2 Harvard University 5,480
  3. 3 National Cancer Institute 3,904
  4. 4 Stanford University 3,330
  5. 5 Scripps Research Institute 2,779

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Monoclonal And Polyclonal Antibodies Research.

41%
Jinho Bang University of Arkansas
41%
Jinho Bang University of Arkansas
32%
Eunyoung Kim University of Arkansas
32%
Eunyoung Kim University of Arkansas
Andrew J. Pierce Ouachita Baptist University
29%
Mary Price UAMS
D. Bae UAMS
27%

Researchers with Federal Grants

Browse All 37 Researchers in Directory